FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine and pharmaceutical industry and represents an agent exhibiting bacteriostatic activity on multiresistant Mycobacterium tuberculosis strains in experiment, representing a water fotoditazin solution in concentration of 4·10-5 mol/l.
EFFECT: invention provides wider range of medicinal agents used to inhibit growth of Mycobacterium tuberculosis.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRESSING THE GROWTH OF MYCOBACTERIUM TUBERCULOSIS POLYRESISTENT STAMPS IN EXPERIMENT | 2016 |
|
RU2628624C1 |
| METHOD FOR INACTIVATION OF DRUG-SENSITIVE AND DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS IN EXPERIMENTAL CONDITIONS IN VITRO | 2018 |
|
RU2702646C1 |
| METHOD FOR DETERMINING THE SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS CULTURES TO PYRAZINAMIDE | 2022 |
|
RU2792782C1 |
| STRAIN MYCOBACTERIUM TUBERCULOSIS 326/18/47 B-9673 FOR EVALUATION OF THE EFFECTIVENESS OF ANTI-TB DRUGS AND DISINFECTANTS | 2022 |
|
RU2785409C1 |
| METHOD FOR MODELING THE DORMANT STATE OF MYCOBACTERIUM TUBERCULOSIS IN VITRO | 2018 |
|
RU2707941C1 |
| (4-(3-HYDROXYPHENYL)PIPERAZINE-1-YL)(5-NITROFURAN-2-YL)METHANON, WHICH HAS ANTITUBERCULAR ACTIVITY AGAINST THE CAUSATIVE AGENT OF MULTIDRUG-RESISTANT TUBERCULOSIS, AND THE METHOD FOR ITS PREPARATION | 2021 |
|
RU2784399C1 |
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
| METHOD FOR DETERMINING GENETIC DETERMINANTS OF RESISTANCE OF THE PATHOGEN OF TUBERCULOSIS TO BEDAQUILINE AND LINEZOLID | 2017 |
|
RU2677293C1 |
| METHOD FOR CARRYING OUT TUBERCULOSTATIC TESTS IN PATIENTS WITH PULMONARY TUBERCULOSIS FOR LABORATORY SUBSTANTIATION OF PERSONIFIED TREATMENT | 2017 |
|
RU2686732C2 |
| DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
